Meeder Advisory Services’s Gilead Sciences GILD Stock Holding History

Meeder Advisory Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.99M	Buy	35,812 +1,722	+5%	+$241K	0.21%	73
2025 Q4	$4.18M	Buy	34,090 +1,684	+5%	+$205K	0.18%	83
2025 Q3	$3.6M	Buy	32,406 +747	+2%	+$84.9K	0.17%	94
2025 Q2	$3.51M	Buy	31,659 +1,865	+6%	+$198K	0.18%	87
2025 Q1	$3.34M	Buy	29,794 +2,049	+7%	+$211K	0.2%	83
2024 Q4	$2.56M	Buy	27,745 +2,073	+8%	+$187K	0.16%	104
2024 Q3	$2.15M	Sell	25,672 -147	-0.6%	-$11.2K	0.14%	118
2024 Q2	$1.77M	Buy	25,819 +3,802	+17%	+$254K	0.13%	133
2024 Q1	$1.61M	Buy	22,017 +1,209	+6%	+$93K	0.16%	107
2023 Q4	$1.69M	Buy	20,808 +585	+3%	+$45.5K	0.19%	89
2023 Q3	$1.52M	Sell	20,223 -3,903	-16%	-$300K	0.19%	87
2023 Q2	$1.86M	Buy	24,126 +1,761	+8%	+$140K	0.2%	90
2023 Q1	$1.86M	Buy	22,365 +1,190	+6%	+$98.6K	0.21%	85
2022 Q4	$1.82M	Buy	+21,175	New	+$1.68M	0.23%	81

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Meeder Advisory Services's GILD Position: Q1 2026 in Review

Meeder Advisory Services increased its Gilead Sciences (GILD) stake by 5.1% in Q1 2026, buying an estimated $241K and bringing the position to 35,812 shares worth $4.99M. The position accounts for 0.21% of the portfolio, ranked #73.

Meeder Advisory Services first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Meeder Advisory Services held 35,812 shares of Gilead Sciences worth $4.99M as of Q1 2026.
Meeder Advisory Services bought 1,722 Gilead Sciences shares in Q1 2026, an estimated $241K.
Gilead Sciences made up 0.21% of Meeder Advisory Services's portfolio in Q1 2026, its #73 holding.
Meeder Advisory Services first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.